| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Hill Path Capital LP | 20.6% | +11.1% | $140M | 7.12M | 0% | Hill Path Capital LP | Apr 7, 2025 | |
| BlackRock, Inc. | 12.1% | $92.2M | 4.67M | BlackRock, Inc. | Mar 31, 2025 | |||
| VANGUARD GROUP INC | 8.81% | -15.3% | $91.7M | -$15.7M | 3.05M | -14.6% | The Vanguard Group | Jun 30, 2025 |
| EMINENCE CAPITAL, LP | 7.5% | $57.3M | 2.91M | Eminence Capital, LP | Mar 31, 2025 | |||
| Patient Capital Management, LLC | 5.72% | $43.4M | 2.2M | Patient Capital Management, LLC | Mar 31, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 42.3M | $768M | +$25M | $18.16 | 181 |
| 2025 Q2 | 40.3M | $1.21B | -$129M | $30.08 | 189 |
| 2025 Q1 | 45.6M | $801M | -$84.9M | $17.57 | 184 |
| 2024 Q4 | 48.6M | $1.42B | +$2.28M | $29.19 | 190 |
| 2024 Q3 | 48.1M | $1.64B | +$61M | $34.05 | 223 |
| 2024 Q2 | 46.2M | $1.84B | -$95.6M | $39.81 | 222 |
| 2024 Q1 | 46.5M | $2.91B | +$190M | $62.60 | 231 |
| 2023 Q4 | 43.7M | $2.36B | +$22.7M | $53.85 | 215 |
| 2023 Q3 | 43.9M | $1.63B | -$33.1M | $37.07 | 205 |
| 2023 Q2 | 44.4M | $1.98B | -$226M | $44.56 | 215 |
| 2023 Q1 | 50.1M | $1.84B | -$22M | $36.79 | 224 |
| 2022 Q4 | 51M | $1.81B | +$39.5M | $35.44 | 224 |
| 2022 Q3 | 49.2M | $1.53B | +$18.9M | $31.03 | 212 |
| 2022 Q2 | 48.8M | $1.6B | -$20.6M | $32.78 | 221 |
| 2022 Q1 | 47.4M | $2.32B | +$164M | $49.10 | 240 |
| 2021 Q4 | 44.6M | $1.71B | -$78.3M | $38.40 | 209 |
| 2021 Q3 | 45.1M | $1.73B | -$14.1M | $38.33 | 195 |
| 2021 Q2 | 45.3M | $1.84B | -$140M | $40.60 | 207 |
| 2021 Q1 | 48.4M | $2.32B | -$43.7M | $47.90 | 217 |
| 2020 Q4 | 49.4M | $1.48B | +$93.5M | $30.02 | 173 |
| 2020 Q3 | 47.2M | $715M | +$105M | $15.16 | 156 |
| 2020 Q2 | 40.4M | $538M | +$102M | $13.33 | 162 |
| 2020 Q1 | 32.8M | $429M | -$128M | $13.08 | 149 |
| 2019 Q4 | 35.2M | $1.41B | -$63.3M | $40.17 | 200 |
| 2019 Q3 | 36.5M | $1.42B | -$209M | $38.95 | 204 |
| 2019 Q2 | 41.6M | $1.68B | -$54.2M | $40.47 | 230 |
| 2019 Q1 | 42.2M | $2.11B | -$77.5M | $49.87 | 251 |
| 2018 Q4 | 44.1M | $1.96B | -$74.8M | $44.56 | 242 |
| 2018 Q3 | 43.9M | $2.91B | +$130M | $66.22 | 256 |
| 2018 Q2 | 43M | $2.05B | -$161M | $47.60 | 229 |
| 2018 Q1 | 45.6M | $1.9B | -$12.2M | $41.74 | 236 |
| 2017 Q4 | 46.6M | $2.57B | +$72.2M | $55.17 | 249 |
| 2017 Q3 | 45.3M | $2.38B | -$24.5M | $52.48 | 246 |
| 2017 Q2 | 45.3M | $3.01B | +$748K | $66.51 | 250 |
| 2017 Q1 | 45.9M | $2.8B | +$318M | $61.09 | 231 |
| 2016 Q4 | 45.5M | $2.56B | +$45.8M | $56.30 | 228 |
| 2016 Q3 | 45.4M | $1.78B | +$21.5M | $39.18 | 183 |
| 2016 Q2 | 44.4M | $2.08B | +$52.5M | $46.79 | 203 |
| 2016 Q1 | 43.6M | $1.69B | +$140M | $38.78 | 163 |
| 2015 Q4 | 40.2M | $1.68B | +$208M | $41.74 | 162 |
| 2015 Q3 | 35.2M | $1.33B | -$178M | $37.83 | 137 |
| 2015 Q2 | 40.2M | $1.44B | +$23.8M | $36.09 | 139 |
| 2015 Q1 | 39.4M | $1.2B | +$36.4M | $30.46 | 86 |
| 2014 Q4 | 38.3M | $1.05B | +$1.05B | $27.30 | 59 |